{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:54:17Z","timestamp":1788202457626,"version":"build-2803163510"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Studies assessing the relationship between disease activity and quality of life (QoL) in adults with atopic dermatitis (AD), before and after therapy are lacking. The relation between disease activity and QoL in AD patients was evaluated before (<jats:italic>t<\/jats:italic>\u2003=\u20030) and after 6\u2003weeks (<jats:italic>t<\/jats:italic>\u2003=\u20036) of treatment with cyclosporin 5\u2003mg\/kg.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> In 54 patients with severe AD, disease activity was assessed using objective Scoring Atopic Dermatitis index (SCORAD), Six Area Six Sign Atopic Dermatitis (SASSAD), \u2018rule of nines\u2019 extent score and serum levels of thymus and activation\u2010regulated chemokine (TARC). Patients filled out the Dermatology Life Quality Index (DLQI). To study the relation between disease activity and QoL, correlations were calculated and regression analysis was performed.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> At <jats:italic>t<\/jats:italic>\u2003=\u20030 there was a small, non\u2010significant correlation between the DLQI and the objective SCORAD, \u2018rule of nines\u2019 or serum TARC levels. At <jats:italic>t<\/jats:italic>\u2003=\u20036 the objective SCORAD, serum TARC and the \u2018rule of nines\u2019 score showed moderate and significant correlations with the DLQI (<jats:italic>r<\/jats:italic>\u2003=\u20030.34, <jats:italic>P\u2003<\/jats:italic>=\u20030.02; <jats:italic>r<\/jats:italic>\u2003=\u20030.31, <jats:italic>P\u2003<\/jats:italic>=\u20030.03; <jats:italic>r<\/jats:italic>\u2003=\u20030.49, <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.001). An individual\u2019s improvement in disease activity (objective SCORAD, SASSAD and \u2018rule of nines\u2019) with 10 points was associated with an improvement of 1.3, 1.5 and 1.1 points respectively in DLQI.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Disease activity correlated better with QoL when disease activity was less severe and disease extent (\u2018rule of nines\u2019) correlated better with QoL than disease severity. An individual\u2019s improvement of 10 points in disease activity was accompanied by only a small improvement in QoL. Other factors than disease activity may influence QoL in patients with AD.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2011.04043.x","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T11:42:17Z","timestamp":1300966937000},"page":"236-241","source":"Crossref","is-referenced-by-count":42,"title":["Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis"],"prefix":"10.1111","volume":"26","author":[{"given":"I.M.","family":"Haeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.A.","family":"van Velsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"de Bruin\u2010Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.F.M.","family":"Bruijnzeel\u2010Koomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.5541510.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08832.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000109358"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701142"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90005-6"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000245677"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.08.011"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb00706.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12251.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90134-B"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02716.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.1907.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68340-2"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08112.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.007"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04938.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113237"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.07.056"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08978.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07050.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05378.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05776.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03906.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.4.454"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.027"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23621.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01704.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06502.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.2478\/v10001-008-0034-8"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00540020"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1993.tb04021.x"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1972.tb05072.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(96)00553-1"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1037\/h0037085"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(91)90120-D"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1221"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/13548500601073928"},{"key":"e_1_2_5_40_2","article-title":"Minimum clinically important difference in Dermatology Life Quality Index in moderate to severe plaque psoriasis patients treated with adalimumab","volume":"54","author":"Melilli L","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-3-36"},{"issue":"62","key":"e_1_2_5_42_2","first-page":"50","article-title":"Clinical meaning of change in Dermatology Life Quality Index scores","volume":"147","author":"Khilji FA","year":"2002","journal-title":"Br J Dermatol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2011.04043.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2011.04043.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:58:26Z","timestamp":1697385506000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2011.04043.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1468-3083.2011.04043.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04043.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}